Thermo Fisher Scientific Inc. (NYSE:TMO) saw a downside of -0.48% to close Tuesday at $575.91 after subtracting -$2.75 on the day. The 5-day average trading volume is 940,160 shares of the company’s common stock. It has gained $589.56 in the past week. An average of 1,543,615 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,183,436.
TMO’s 1-month performance is 3.00% or $3.95 on its low of $549.18 reached on 09/13/21. The company’s shares have touched a 52-week low of $433.52 and high of $616.93, with the stock’s rally to the 52-week high happening on 09/24/21. YTD, TMO has achieved 23.64% or $110.13. However, the current price is down -6.65%% from the 52-week high price.
A Backdoor Way To Profit From Today’s Crypto Bull Market
In any crypto bull market, there's a lot of money to be made.
But what if we told you the best opportunities are not cryptocurrencies themselves… but instead, simply crypto stocks?
This strategy is simply and ridiculously easy.
Here are 6 ways to gain exposure to crypto outside the norm. This is arguably the safest bet you can make.
On Aug 09, 65 days have gone by since the last insider trading activity for Thermo Fisher Scientific Inc. (TMO). Holmes Joseph R. (VP & Chief Accounting Officer) most recently sold 759 shares at $542.75 per share on Aug 09. This transaction cost the insider $411,948. Chairman & CEO, CASPER MARC N, sold 10,000 shares at a price of $539.93 on Aug 05. Then, on Aug 04, Chairman & CEO CASPER MARC N sold 10,000 shares at a price of $539.05 per share. This transaction amounted to $5,390,468.
The company’s PE ratio for the last five years has touched a high of 47.73 and a low of 22.21. TMO stock has a beta of 0.70. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 5.92 while the price-to-book (PB) in the most recent quarter is 6.14, with the price to cash flow ratio at 29.15.
Thermo Fisher Scientific Inc. pays an annual dividend of $1.04 per share. Its dividend yield is 0.18% and the payout ratio is 4.20%. TMO paid $0.26 a share compared with prior rate of $0.26, down 0.0% from last year’s. The company has boosted its dividend for the last 1 consecutive years with the latest dividend increase of $0.04 reported on Tuesday February 23 2021. Measured over the last 3 years, the Dividend has been growing by 46.67% yearly.
It is projected that Thermo Fisher Scientific Inc.’s next ex-dividend date will be on 15-Dec. TMO is expected to distribute $0.26 as its next dividend.
Thermo Fisher Scientific Inc.’s quick ratio for the period ended June 29 was 2.10, with the current ratio over the same period at 2.80 meaning that TMO stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.51, while the total debt to equity was 0.51. In terms of profitability, the gross margin trailing 12 months is 51.30%. The trailing 12-month EBITDA margin is 31.82% while for the period ending June 29; Thermo Fisher Scientific Inc.’s operating margin was 28.00%. The firm’s gross profit as reported stood at $16.0 billion against revenue of $32.22 billion.
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 25.41% to $9.27 billion, while revenue of $9.91 billion was -6.83% off the previous quarter. Analysts expected TMO to announce $5.44 per share in earnings in its latest quarter, but it posted $5.6, representing a 2.90% surprise. EBITDA for the quarter stood at more than $2.82 billion. TMO stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 30.84 billion, with total debt at $18.79 billion. Shareholders hold equity totaling $393.42 million
Let’s look briefly at Thermo Fisher Scientific Inc. (TMO) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 46.77% to suggest the stock is trending Neutral, with historical volatility in this time period at 13.05%.
The stock’s 5-day moving average is $579.52, reflecting a +0.70% or $4.03 change from its current price. TMO is currently trading +2.40% above its 20-day SMA, +23.77% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by +7.91% and +25.72% respectively.
Stochastic %K and %D was 42.34% and 44.42% and the average true range (ATR) pointed at 13.58. The RSI (14) points at 50.39%, while the 14-day stochastic is at 36.81% with the period’s ATR at 13.53. The stock’s 9-day MACD Oscillator is pointing at 3.66 and -2.74 on the 14-day charts.
Analysts offering their rating for TMO stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate TMO as a “sell,”, while 3 advise that investors “Hold.” 1 analysts have rated the stock as underweight. 4 rates the stock as overweight while 14 have offered a “buy” rating.
What is TMO’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $540.00 and a high of $710.00, with their median price target at $662.50. Looking at these predictions, the average price target given by analysts is for Thermo Fisher Scientific Inc. (TMO) stock is $649.31.